Baker & Eastlack Ventures

OcuDoc, Inc., based in Columbus, Ohio, is a MedTech startup specializing in innovative eye care technologies. The company has developed OcuDoc Mobile, a pioneering smartphone application that offers accurate and rapid autorefraction and Telerefraction without requiring additional equipment. This platform allows for precise measurement of refractive errors and eye alignment, significantly enhancing the accuracy and efficiency of eye examinations conducted by optometrists. Through its advancements in vision diagnostics, OcuDoc aims to improve the overall eye care experience for both practitioners and patients.

MatriSys Bioscience, Inc. is a clinical stage biopharmaceutical company based in La Jolla, California, focused on developing and commercializing microbiome therapies for the dermatology and skin care markets. Founded in 2015, the company is advancing its lead product, MSB-01, a topical antimicrobial live biotherapeutic designed to restore the balance of skin bacteria in patients with atopic dermatitis. This innovative treatment aims to enhance host defense by reintroducing beneficial bacteria that are often deficient in these patients. Additionally, MatriSys produces cosmetic ingredients derived from its proprietary bacterial strains, which are formulated to address various skin concerns such as scaling, flaking, and signs of aging. The company's products are marketed through prescription dermatology channels as well as skin care and cosmetic routes, and its therapies are currently undergoing Phase I/II clinical trials.

Zerigo Health, formerly known as Clarify Medical, Inc., specializes in home therapy solutions for chronic skin conditions such as psoriasis, eczema, and vitiligo. The company offers innovative products like the Clarify mobile ultra violet B treatment system and the Home Light Therapy System, both designed to facilitate phototherapy in a home setting. Zerigo Health aims to enhance the ease and effectiveness of UVB therapy through a connected system that allows patients to manage their treatment via a smartphone app. This app enables users to control dosing, frequency, and duration of therapy, ensuring adherence to guidelines set by dermatology experts. By allowing patients to administer their treatments with clinical precision, Zerigo Health improves the overall patient experience, while also monitoring compliance and progress, ultimately empowering individuals to manage their chronic skin conditions more effectively from the comfort of their homes.

Lentechs is a medical device company based in Columbus, Ohio, specializing in the development of innovative soft bifocal contact lenses. The company focuses on creating a new generation of soft, suspended progressive contact lenses that enhance user experience by allowing natural eye movement, similar to that achieved with traditional bifocal glasses. This design aims to provide improved comfort and visual clarity, enabling users to see freely without discomfort. Lentechs is dedicated to addressing the needs of patients throughout their lifecycle, ensuring that its products offer both functionality and ease of use.

Neurvana Medical LLC, founded in 2016 and based in Tustin, California, specializes in the design, development, and commercialization of neurovascular therapeutic devices. The company focuses on creating innovative devices aimed at achieving superior clinical outcomes in neurovascular care. By prioritizing high standards of care, Neurvana Medical aims to provide effective solutions that enhance patient outcomes in the treatment of neurovascular conditions.

UroDev Medical is a company focused on developing innovative medical devices aimed at enhancing the quality of life for individuals with spinal cord injuries and diseases. Its flagship product, The Connected Catheter, introduces a semi-permanent, minimally-invasive smart catheter system. This device measures bladder pressure and wirelessly transmits data to a smartphone, streamlining bladder management for users. By eliminating the need for intermittent catheters and drainage bags, UroDev Medical enables both users and clinicians to effectively control the valve that facilitates urine drainage from the bladder.

Kurin is a privately held, certified minority-owned business committed to enhancing healthcare through innovative and cost-effective technologies. The company specializes in medical device engineering, marketing, sales, and service, with a focus on addressing the challenges posed by false positive blood cultures. Building on the success of its Curos disinfecting port protectors, Kurin has developed the Kurin Lock technology. This technology aims to reduce blood culture contamination by allowing the initial blood sample to be sidelined before collecting the test sample, thereby minimizing the risk of contamination from the initial draw. With a strong emphasis on customer focus and agile development, Kurin strives to gain caregiver acceptance and become the standard of care in hospitals.